Key result
HPSD and electroporation ablation show potential to cut collateral damage and procedure times in AF.
Why the study?
Long-term lesion durability remains unsatisfactory in AF ablation, rare life-threatening complications persist, and more extensive ablation increases collateral injury risk.
Does high power-short duration radiofrequency or electroporation ablation improve efficacy and safety in patients with atrial fibrillation?
Does high power-short duration radiofrequency or electroporation ablation improve efficacy and safety in patients with atrial fibrillation?
Novel non-thermal and high-power short-duration ablation techniques hold promise for safer and faster AF ablation, but robust RCT data are currently lacking.
May reduce AF ablation times and injury risk; leaves open confirmation of durable efficacy and safety in RCTs.
Despite substantial technological and procedural advances that have improved the efficacy and safety of AF ablation in recent years, the long-term durability of ablation lesions is still not satisfactory. There also remains concern regarding rare but potentially life-threatening procedure-related complications like cardiac tamponade and atrioesophageal fistulae. Current ablation strategies are aiming to optimize the trade-off between efficacy and safety, where more extensive ablation appears to inevitably increase the risk of collateral injury. However, new forms of energy application may have the potential to resolve this quandary. The emerging concept of high power-short duration radiofrequency ablation features a more favorable lesion geometry that appears ideally suited to create contiguous lesions in the thin-walled atrium. Moreover, novel non-thermal ablation methods based on electroporation appear to provide a unique selectivity for cardiomyocytes and to spare surrounding tissues composed of other cell types. Both, high power-short duration and electroporation ablation might have the potential to break the trade-off between effective lesions and collateral damage and to substantially improve risk-benefit ratios in AF ablation. In addition, both approaches lead to considerable reductions in ablation times. However, their putative benefits regarding efficacy, efficiency, and safety remain to be proven in randomized controlled trials.
No takes yet. Share an insight, caveat, or question.
Althoff et al. (2021) conducted a review in Atrial fibrillation. High power-short duration radiofrequency and electroporation ablation vs. Conventional radiofrequency ablation was evaluated. High power-short duration and electroporation ablation techniques show potential to improve the efficacy and safety of atrial fibrillation ablation by reducing collateral damage and procedure times.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: